GLP-1 receptor agonists enhance insulin secretion, slow gastric emptying, and reduce appetite
Glycemic fluctuations caused by COVID-19: Results from continuous glucose monitoring
The most commonly reported side effects in clinical trials include injection site reactions (redness, swelling, itching), fluid retention, joint pain, and in some cases transient glucose elevation
for some, GLP-1s have offered a powerful tool in managing obesity and achieving healthier body weights, which in turn can lead to a cascade of other positive health outcomes, an improved sense of well-being, and key for retailers an evolution in what products they buy
Our study objectives were to review data on hydroquinone-associated ochronosis to determine risk factors for patients experiencing this adverse event